ID

45899

Beskrivning

Principal Investigator: Donald Bowden, PhD, Center for Human Genomics, Center for Diabetes Research, Wake Forest University School of Medicine, Winston-Salem, NC, USA MeSH: Diabetes Mellitus, Type 2 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001167 *The T2D Seq GWAS AA Cohort is utilized in the following dbGaP sub-studies.* To view genotypes, other molecular data, and derived variables collected in these sub-studies, please click on the following sub-studies below or in the "Sub-studies" box located on the right hand side of this top-level study page phs001167 T2D Seq GWAS AA Cohort.- phs000140 CIDR T2D Bowdens - phs001102 T2D GENES AA

Länk

dbGaP study = phs001167

Nyckelord

  1. 2023-12-12 2023-12-12 - Simon Heim
Rättsinnehavare

Donald Bowden, PhD, Center for Human Genomics, Center for Diabetes Research, Wake Forest University School of Medicine, Winston-Salem, NC, USA

Uppladdad den

12 december 2023

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :


Inga kommentarer

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

dbGaP phs001167 Type 2 Diabetes in African Americans, GWAS and Exome Sequencing

Subject ID, sample ID, sample source, source sample ID, sample use, if sample was used in analysis, and reason why sample was used in analysis of participants with or without T2D and involved in the "Type 2 Diabetes in African Americans, GWAS and Exome Sequencing" project.

  1. StudyEvent: SEV1
    1. Subject ID, race, age, gender, BMI, consent form(s) signed by participants, age of type 2 diabetes Mellitus diagnosis, age of end stage renal disease diagnosis, age of hypertension diagnosis, duration of type 2 diabetes Mellitus since diagnosis, individual has reported that he/she is on dialysis, individual has reported hypertension, individual has diabetic retinopathy reported by ophthalmologist or laser treatment with photocoagulation, HBA1C, pc1, pc2, pc3, pc4, pc5, pc6, pc7, pc8, pc9, and pc10 of participants with T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
    2. Subject ID, race, age, gender, BMI, fasting blood sugar, consent form(s) signed by participant, participant is fasting when he has not had anything to eat or drink 12 hours prior to blood draw, pc1, pc2, pc3, pc4, pc5, pc6, pc7, pc8, pc9, and pc10 of participants without T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
    3. Subject ID, family ID, mother ID, father ID, gender, and monozygotic tween ID of participants with of without T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
    4. Subject ID, consent group, subject source, source subject ID, and affection status of participants with or without T2D and involved in the "Type 2 Diabetes in African Americans, GWAS and Exome Sequencing" project.
    5. Subject ID, sample ID, sample source, source sample ID, sample use, if sample was used in analysis, and reason why sample was used in analysis of participants with or without T2D and involved in the "Type 2 Diabetes in African Americans, GWAS and Exome Sequencing" project.
    6. Subject ID, gender, age, T2D, diabetes age of diagnosis at time of study, height, weight, BMI, consortium name, and cohort name of participants with or without T2D and involved in the "Type 2 Diabetes Genetic Exploration by Next-generation Sequencing in Multi-Ethnic Samples (T2D-GENES) Project 1: Wake Forest African American Type 2 Diabetes" project.
    7. Sample ID, body site where sample was obtained, analyte type, histological type of sample, sequencing center, and tumor status of participants with or without T2D and involved in the "Type 2 Diabetes Genetic Exploration by Next-generation Sequencing in Multi-Ethnic Samples (T2D-GENES) Project 1: Wake Forest African American Type 2 Diabetes" project.
    8. Sample ID, analyte type, body site, and tumor status of participants with or without T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
pht005637
Beskrivning

pht005637

Alias
UMLS CUI [1,1]
C3846158
Subject ID
Beskrivning

SUBJID

Datatyp

string

Alias
UMLS CUI [1,1]
C2348585
Sample ID
Beskrivning

SAMPID

Datatyp

string

Alias
UMLS CUI [1,1]
C1299222
Source repository where samples originate
Beskrivning

SAMP_SOURCE

Datatyp

string

Alias
UMLS CUI [1,1]
C3847505
UMLS CUI [1,2]
C0449416
UMLS CUI [1,3]
C2347026
Sample ID used in the Source Repository
Beskrivning

SOURCE_SAMPID

Datatyp

string

Alias
UMLS CUI [1,1]
C1299222
UMLS CUI [1,2]
C3847505
UMLS CUI [1,3]
C0449416
Was sample used in analysis?
Beskrivning

Use in analysis

Datatyp

text

Alias
UMLS CUI [1,1]
C2347026
UMLS CUI [1,2]
C1524063
Why sample was not included in analysis?
Beskrivning

Reason

Datatyp

text

Alias
UMLS CUI [1,1]
C0684328
UMLS CUI [1,2]
C2828389
UMLS CUI [1,3]
C0370003
UMLS CUI [1,4]
C0936012
Study accession ID
Beskrivning

STUDY

Datatyp

text

Alias
UMLS CUI [1,1]
C1510755
UMLS CUI [1,2]
C0947630
Sample Use
Beskrivning

SAMPLE_USE

Datatyp

text

Alias
UMLS CUI [1,1]
C2347026
UMLS CUI [1,2]
C1524063

Similar models

Subject ID, sample ID, sample source, source sample ID, sample use, if sample was used in analysis, and reason why sample was used in analysis of participants with or without T2D and involved in the "Type 2 Diabetes in African Americans, GWAS and Exome Sequencing" project.

  1. StudyEvent: SEV1
    1. Subject ID, race, age, gender, BMI, consent form(s) signed by participants, age of type 2 diabetes Mellitus diagnosis, age of end stage renal disease diagnosis, age of hypertension diagnosis, duration of type 2 diabetes Mellitus since diagnosis, individual has reported that he/she is on dialysis, individual has reported hypertension, individual has diabetic retinopathy reported by ophthalmologist or laser treatment with photocoagulation, HBA1C, pc1, pc2, pc3, pc4, pc5, pc6, pc7, pc8, pc9, and pc10 of participants with T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
    2. Subject ID, race, age, gender, BMI, fasting blood sugar, consent form(s) signed by participant, participant is fasting when he has not had anything to eat or drink 12 hours prior to blood draw, pc1, pc2, pc3, pc4, pc5, pc6, pc7, pc8, pc9, and pc10 of participants without T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
    3. Subject ID, family ID, mother ID, father ID, gender, and monozygotic tween ID of participants with of without T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
    4. Subject ID, consent group, subject source, source subject ID, and affection status of participants with or without T2D and involved in the "Type 2 Diabetes in African Americans, GWAS and Exome Sequencing" project.
    5. Subject ID, sample ID, sample source, source sample ID, sample use, if sample was used in analysis, and reason why sample was used in analysis of participants with or without T2D and involved in the "Type 2 Diabetes in African Americans, GWAS and Exome Sequencing" project.
    6. Subject ID, gender, age, T2D, diabetes age of diagnosis at time of study, height, weight, BMI, consortium name, and cohort name of participants with or without T2D and involved in the "Type 2 Diabetes Genetic Exploration by Next-generation Sequencing in Multi-Ethnic Samples (T2D-GENES) Project 1: Wake Forest African American Type 2 Diabetes" project.
    7. Sample ID, body site where sample was obtained, analyte type, histological type of sample, sequencing center, and tumor status of participants with or without T2D and involved in the "Type 2 Diabetes Genetic Exploration by Next-generation Sequencing in Multi-Ethnic Samples (T2D-GENES) Project 1: Wake Forest African American Type 2 Diabetes" project.
    8. Sample ID, analyte type, body site, and tumor status of participants with or without T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
pht005637
C3846158 (UMLS CUI [1,1])
SUBJID
Item
Subject ID
string
C2348585 (UMLS CUI [1,1])
SAMPID
Item
Sample ID
string
C1299222 (UMLS CUI [1,1])
SAMP_SOURCE
Item
Source repository where samples originate
string
C3847505 (UMLS CUI [1,1])
C0449416 (UMLS CUI [1,2])
C2347026 (UMLS CUI [1,3])
SOURCE_SAMPID
Item
Sample ID used in the Source Repository
string
C1299222 (UMLS CUI [1,1])
C3847505 (UMLS CUI [1,2])
C0449416 (UMLS CUI [1,3])
Item
Was sample used in analysis?
text
C2347026 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
Code List
Was sample used in analysis?
CL Item
Data removed from analysis (no)
C1511726 (UMLS CUI [1,1])
C1883720 (UMLS CUI [1,2])
C0936012 (UMLS CUI [1,3])
CL Item
Data used in analysis (yes)
C1511726 (UMLS CUI [1,1])
C0457083 (UMLS CUI [1,2])
C0936012 (UMLS CUI [1,3])
Item
Why sample was not included in analysis?
text
C0684328 (UMLS CUI [1,1])
C2828389 (UMLS CUI [1,2])
C0370003 (UMLS CUI [1,3])
C0936012 (UMLS CUI [1,4])
Code List
Why sample was not included in analysis?
CL Item
T2DM only (1)
C4014362 (UMLS CUI [1,1])
CL Item
ESRD only (2)
CL Item
Low African admixture (3)
CL Item
Duplicate (4)
STUDY
Item
Study accession ID
text
C1510755 (UMLS CUI [1,1])
C0947630 (UMLS CUI [1,2])
Item
Sample Use
text
C2347026 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
Code List
Sample Use
CL Item
SNP genotypes obtained using standard or custom microarrays (Array_SNP)
C2347026 (UMLS CUI [1,1])
C0042153 (UMLS CUI [1,2])
C0752046 (UMLS CUI [1,3])
C1449575 (UMLS CUI [1,4])
CL Item
SNP genotypes derived from sequence data (Seq_DNA_SNP)
C0752046 (UMLS CUI [1,1])
C0017431 (UMLS CUI [1,2])
C4727174 (UMLS CUI [1,3])

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial